Medical Device Pulmonary Drug Delivery Devices/Sys...

Pulmonary Drug Delivery Devices/Systems Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Capsule Endoscopy, Drug Delivery, Patient Monitoring) By Application (Asthma, COPD, Allergic Rhinitis, Cystic Fibrosis and Others) and By End User (Hospitals & Clinics, Research Institutes and Home Healthcare)

Report Code: TIPHE100001256 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Pulmonary drug delivery devices or systems includes devices for delivering drugs through medical devices such as inhalers and nebulizers in patients with respiratory illnesses such as asthma. The devices are based on diverse delivery mechanisms and consist of types of drug formulations. Asthma, COPD, Allergic Rhinitis and Cystic Fibrosis are major respiratory diseases which require the use of drug delivery devices in case of emergency as well.

MARKET SCOPE

The "Pulmonary Drug Delivery Devices Systems Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pulmonary drug delivery devices systems market with detailed market segmentation by product, application, end user, and geography. The pulmonary drug delivery devices systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pulmonary drug delivery devices systems market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on the product pulmonary drug delivery devices systems market is segmented as Metered dose inhalers (MDIs), Dry powder inhalers (DPIs, Nebulizers and Accessories.
  •   Based on application, the market is segmented into asthma, COPD, allergic rhinitis, cystic fibrosis and others
  •   Based on the end use the market is segmented as hospitals & clinics and home healthcare.

    MARKET DYNAMICS

    Drivers

    •   Rising prevalence of respiratory diseases and growing healthcare expenditure.
    •   Rising healthcare awareness and increasing technological advancements
    •   Uses of respiratory care devices as a part of home healthcare

    Restraints

    •   Regulatory hurdles.

    REGIONAL FRAMEWORK

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Pulmonary Drug Delivery Devices Systems market based on various segments. It also provides market size and forecast estimates from year 2018 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Pulmonary Drug Delivery Devices Systems market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

    The report analyzes factors affecting Pulmonary Drug Delivery Devices Systems market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Pulmonary Drug Delivery Devices Systems market in these regions.

    IMPACT OF COVID-19 ON PULMONARY DRUG DELIVERY DEVICES SYSTEMS MARKET
    COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The pulmonary drug delivery devices systems market registered a growth in COVID-19 pandemic times as more physician worked on investigating the respiratory health of the virus affected people.

    MARKET PLAYERS

    The report covers key developments in the Pulmonary Drug Delivery Devices Systems market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Pulmonary Drug Delivery Devices Systems market are anticipated to have lucrative growth opportunities in the future with the rising demand for Pulmonary Drug Delivery Devices Systems in the global market. Below mentioned is the list of few companies engaged in the Pulmonary Drug Delivery Devices Systems market.

    The report also includes the profiles of key players in Pulmonary Drug Delivery Devices Systems market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

    •   GlaxoSmithKline plc.
    •   Koninklijke Philips N.V.
    •   Boehringer Ingelheim International GmbH
    •   3M
    •   AstraZeneca
    •   Teva Pharmaceutical Industries Ltd.
    •   Aerogen Ltd.
    •   Hovione
    •   Hantel Technologies
    •   H&T Presspart Manufacturing Ltd..

    The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
    • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Pulmonary Drug Delivery Devices Systems Market - By Product
    1.3.2 Pulmonary Drug Delivery Devices Systems Market - By Application
    1.3.3 Pulmonary Drug Delivery Devices Systems Market - By End Use
    1.3.4 Pulmonary Drug Delivery Devices Systems Market - By Region
    1.3.4.1 By Country
    2. KEY TAKEAWAYS
    3. RESEARCH METHODOLOGY
    4. PULMONARY DRUG DELIVERY DEVICES SYSTEMS MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS
    5. PULMONARY DRUG DELIVERY DEVICES SYSTEMS MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
    6. PULMONARY DRUG DELIVERY DEVICES SYSTEMS MARKET - GLOBAL MARKET ANALYSIS
    6.1. PULMONARY DRUG DELIVERY DEVICES SYSTEMS - GLOBAL MARKET OVERVIEW
    6.2. PULMONARY DRUG DELIVERY DEVICES SYSTEMS - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING
    7. PULMONARY DRUG DELIVERY DEVICES SYSTEMS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
    7.1. OVERVIEW
    7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
    7.3. METERED DOSE INHALERS (MDIS)
    7.3.1. Overview
    7.3.2. Metered dose inhalers (MDIs) Market Forecast and Analysis
    7.4. DRY POWDER INHALERS (DPIS
    7.4.1. Overview
    7.4.2. Dry powder inhalers (DPIs Market Forecast and Analysis
    7.5. NEBULIZERS
    7.5.1. Overview
    7.5.2. Nebulizers Market Forecast and Analysis
    7.6. ACCESSORIES
    7.6.1. Overview
    7.6.2. Accessories Market Forecast and Analysis
    8. PULMONARY DRUG DELIVERY DEVICES SYSTEMS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
    8.1. OVERVIEW
    8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
    8.3. ASTHMA
    8.3.1. Overview
    8.3.2. Asthma Market Forecast and Analysis
    8.4. COPD
    8.4.1. Overview
    8.4.2. COPD Market Forecast and Analysis
    8.5. ALLERGIC RHINITIS
    8.5.1. Overview
    8.5.2. Allergic Rhinitis Market Forecast and Analysis
    8.6. CYSTIC FIBROSIS
    8.6.1. Overview
    8.6.2. Cystic fibrosis Market Forecast and Analysis
    8.7. OTHERS
    8.7.1. Overview
    8.7.2. Others Market Forecast and Analysis
    9. PULMONARY DRUG DELIVERY DEVICES SYSTEMS MARKET - REVENUE AND FORECASTS TO 2028 - END USE
    9.1. OVERVIEW
    9.2. END USE MARKET FORECASTS AND ANALYSIS
    9.3. HOSPITALS AND CLINICS
    9.3.1. Overview
    9.3.2. Hospitals and Clinics Market Forecast and Analysis
    9.4. HOME HEALTHCARE
    9.4.1. Overview
    9.4.2. Home Healthcare Market Forecast and Analysis
    10. PULMONARY DRUG DELIVERY DEVICES SYSTEMS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Pulmonary Drug Delivery Devices Systems Market Overview
    10.1.2 North America Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis
    10.1.3 North America Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Product
    10.1.4 North America Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Application
    10.1.5 North America Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By End Use
    10.1.6 North America Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Pulmonary Drug Delivery Devices Systems Market
    10.1.6.1.1 United States Pulmonary Drug Delivery Devices Systems Market by Product
    10.1.6.1.2 United States Pulmonary Drug Delivery Devices Systems Market by Application
    10.1.6.1.3 United States Pulmonary Drug Delivery Devices Systems Market by End Use
    10.1.6.2 Canada Pulmonary Drug Delivery Devices Systems Market
    10.1.6.2.1 Canada Pulmonary Drug Delivery Devices Systems Market by Product
    10.1.6.2.2 Canada Pulmonary Drug Delivery Devices Systems Market by Application
    10.1.6.2.3 Canada Pulmonary Drug Delivery Devices Systems Market by End Use
    10.1.6.3 Mexico Pulmonary Drug Delivery Devices Systems Market
    10.1.6.3.1 Mexico Pulmonary Drug Delivery Devices Systems Market by Product
    10.1.6.3.2 Mexico Pulmonary Drug Delivery Devices Systems Market by Application
    10.1.6.3.3 Mexico Pulmonary Drug Delivery Devices Systems Market by End Use
    10.2. EUROPE
    10.2.1 Europe Pulmonary Drug Delivery Devices Systems Market Overview
    10.2.2 Europe Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis
    10.2.3 Europe Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Product
    10.2.4 Europe Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Application
    10.2.5 Europe Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By End Use
    10.2.6 Europe Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Pulmonary Drug Delivery Devices Systems Market
    10.2.6.1.1 Germany Pulmonary Drug Delivery Devices Systems Market by Product
    10.2.6.1.2 Germany Pulmonary Drug Delivery Devices Systems Market by Application
    10.2.6.1.3 Germany Pulmonary Drug Delivery Devices Systems Market by End Use
    10.2.6.2 France Pulmonary Drug Delivery Devices Systems Market
    10.2.6.2.1 France Pulmonary Drug Delivery Devices Systems Market by Product
    10.2.6.2.2 France Pulmonary Drug Delivery Devices Systems Market by Application
    10.2.6.2.3 France Pulmonary Drug Delivery Devices Systems Market by End Use
    10.2.6.3 Italy Pulmonary Drug Delivery Devices Systems Market
    10.2.6.3.1 Italy Pulmonary Drug Delivery Devices Systems Market by Product
    10.2.6.3.2 Italy Pulmonary Drug Delivery Devices Systems Market by Application
    10.2.6.3.3 Italy Pulmonary Drug Delivery Devices Systems Market by End Use
    10.2.6.4 Spain Pulmonary Drug Delivery Devices Systems Market
    10.2.6.4.1 Spain Pulmonary Drug Delivery Devices Systems Market by Product
    10.2.6.4.2 Spain Pulmonary Drug Delivery Devices Systems Market by Application
    10.2.6.4.3 Spain Pulmonary Drug Delivery Devices Systems Market by End Use
    10.2.6.5 United Kingdom Pulmonary Drug Delivery Devices Systems Market
    10.2.6.5.1 United Kingdom Pulmonary Drug Delivery Devices Systems Market by Product
    10.2.6.5.2 United Kingdom Pulmonary Drug Delivery Devices Systems Market by Application
    10.2.6.5.3 United Kingdom Pulmonary Drug Delivery Devices Systems Market by End Use
    10.2.6.6 Rest of Europe Pulmonary Drug Delivery Devices Systems Market
    10.2.6.6.1 Rest of Europe Pulmonary Drug Delivery Devices Systems Market by Product
    10.2.6.6.2 Rest of Europe Pulmonary Drug Delivery Devices Systems Market by Application
    10.2.6.6.3 Rest of Europe Pulmonary Drug Delivery Devices Systems Market by End Use
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Pulmonary Drug Delivery Devices Systems Market Overview
    10.3.2 Asia-Pacific Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis
    10.3.3 Asia-Pacific Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Product
    10.3.4 Asia-Pacific Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Application
    10.3.5 Asia-Pacific Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By End Use
    10.3.6 Asia-Pacific Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Pulmonary Drug Delivery Devices Systems Market
    10.3.6.1.1 Australia Pulmonary Drug Delivery Devices Systems Market by Product
    10.3.6.1.2 Australia Pulmonary Drug Delivery Devices Systems Market by Application
    10.3.6.1.3 Australia Pulmonary Drug Delivery Devices Systems Market by End Use
    10.3.6.2 China Pulmonary Drug Delivery Devices Systems Market
    10.3.6.2.1 China Pulmonary Drug Delivery Devices Systems Market by Product
    10.3.6.2.2 China Pulmonary Drug Delivery Devices Systems Market by Application
    10.3.6.2.3 China Pulmonary Drug Delivery Devices Systems Market by End Use
    10.3.6.3 India Pulmonary Drug Delivery Devices Systems Market
    10.3.6.3.1 India Pulmonary Drug Delivery Devices Systems Market by Product
    10.3.6.3.2 India Pulmonary Drug Delivery Devices Systems Market by Application
    10.3.6.3.3 India Pulmonary Drug Delivery Devices Systems Market by End Use
    10.3.6.4 Japan Pulmonary Drug Delivery Devices Systems Market
    10.3.6.4.1 Japan Pulmonary Drug Delivery Devices Systems Market by Product
    10.3.6.4.2 Japan Pulmonary Drug Delivery Devices Systems Market by Application
    10.3.6.4.3 Japan Pulmonary Drug Delivery Devices Systems Market by End Use
    10.3.6.5 South Korea Pulmonary Drug Delivery Devices Systems Market
    10.3.6.5.1 South Korea Pulmonary Drug Delivery Devices Systems Market by Product
    10.3.6.5.2 South Korea Pulmonary Drug Delivery Devices Systems Market by Application
    10.3.6.5.3 South Korea Pulmonary Drug Delivery Devices Systems Market by End Use
    10.3.6.6 Rest of Asia-Pacific Pulmonary Drug Delivery Devices Systems Market
    10.3.6.6.1 Rest of Asia-Pacific Pulmonary Drug Delivery Devices Systems Market by Product
    10.3.6.6.2 Rest of Asia-Pacific Pulmonary Drug Delivery Devices Systems Market by Application
    10.3.6.6.3 Rest of Asia-Pacific Pulmonary Drug Delivery Devices Systems Market by End Use
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Pulmonary Drug Delivery Devices Systems Market Overview
    10.4.2 Middle East and Africa Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis
    10.4.3 Middle East and Africa Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Product
    10.4.4 Middle East and Africa Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Application
    10.4.5 Middle East and Africa Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By End Use
    10.4.6 Middle East and Africa Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Pulmonary Drug Delivery Devices Systems Market
    10.4.6.1.1 South Africa Pulmonary Drug Delivery Devices Systems Market by Product
    10.4.6.1.2 South Africa Pulmonary Drug Delivery Devices Systems Market by Application
    10.4.6.1.3 South Africa Pulmonary Drug Delivery Devices Systems Market by End Use
    10.4.6.2 Saudi Arabia Pulmonary Drug Delivery Devices Systems Market
    10.4.6.2.1 Saudi Arabia Pulmonary Drug Delivery Devices Systems Market by Product
    10.4.6.2.2 Saudi Arabia Pulmonary Drug Delivery Devices Systems Market by Application
    10.4.6.2.3 Saudi Arabia Pulmonary Drug Delivery Devices Systems Market by End Use
    10.4.6.3 U.A.E Pulmonary Drug Delivery Devices Systems Market
    10.4.6.3.1 U.A.E Pulmonary Drug Delivery Devices Systems Market by Product
    10.4.6.3.2 U.A.E Pulmonary Drug Delivery Devices Systems Market by Application
    10.4.6.3.3 U.A.E Pulmonary Drug Delivery Devices Systems Market by End Use
    10.4.6.4 Rest of Middle East and Africa Pulmonary Drug Delivery Devices Systems Market
    10.4.6.4.1 Rest of Middle East and Africa Pulmonary Drug Delivery Devices Systems Market by Product
    10.4.6.4.2 Rest of Middle East and Africa Pulmonary Drug Delivery Devices Systems Market by Application
    10.4.6.4.3 Rest of Middle East and Africa Pulmonary Drug Delivery Devices Systems Market by End Use
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Pulmonary Drug Delivery Devices Systems Market Overview
    10.5.2 South and Central America Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis
    10.5.3 South and Central America Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Product
    10.5.4 South and Central America Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Application
    10.5.5 South and Central America Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By End Use
    10.5.6 South and Central America Pulmonary Drug Delivery Devices Systems Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Pulmonary Drug Delivery Devices Systems Market
    10.5.6.1.1 Brazil Pulmonary Drug Delivery Devices Systems Market by Product
    10.5.6.1.2 Brazil Pulmonary Drug Delivery Devices Systems Market by Application
    10.5.6.1.3 Brazil Pulmonary Drug Delivery Devices Systems Market by End Use
    10.5.6.2 Argentina Pulmonary Drug Delivery Devices Systems Market
    10.5.6.2.1 Argentina Pulmonary Drug Delivery Devices Systems Market by Product
    10.5.6.2.2 Argentina Pulmonary Drug Delivery Devices Systems Market by Application
    10.5.6.2.3 Argentina Pulmonary Drug Delivery Devices Systems Market by End Use
    10.5.6.3 Rest of South and Central America Pulmonary Drug Delivery Devices Systems Market
    10.5.6.3.1 Rest of South and Central America Pulmonary Drug Delivery Devices Systems Market by Product
    10.5.6.3.2 Rest of South and Central America Pulmonary Drug Delivery Devices Systems Market by Application
    10.5.6.3.3 Rest of South and Central America Pulmonary Drug Delivery Devices Systems Market by End Use
    11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PULMONARY DRUG DELIVERY DEVICES SYSTEMS MARKET
    11.1 North America
    11.2 Europe
    11.3 Asia-Pacific
    11.4 Middle East and Africa
    11.5 South and Central America
    12. INDUSTRY LANDSCAPE
    12.1. MERGERS AND ACQUISITIONS
    12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    12.3. NEW PRODUCT LAUNCHES
    12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    13. PULMONARY DRUG DELIVERY DEVICES SYSTEMS MARKET, KEY COMPANY PROFILES
    13.1. GLAXOSMITHKLINE PLC.
    13.1.1. Key Facts
    13.1.2. Business Description
    13.1.3. Products and Services
    13.1.4. Financial Overview
    13.1.5. SWOT Analysis
    13.1.6. Key Developments
    13.2. KONINKLIJKE PHILIPS N.V.
    13.2.1. Key Facts
    13.2.2. Business Description
    13.2.3. Products and Services
    13.2.4. Financial Overview
    13.2.5. SWOT Analysis
    13.2.6. Key Developments
    13.3. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    13.3.1. Key Facts
    13.3.2. Business Description
    13.3.3. Products and Services
    13.3.4. Financial Overview
    13.3.5. SWOT Analysis
    13.3.6. Key Developments
    13.4. 3M
    13.4.1. Key Facts
    13.4.2. Business Description
    13.4.3. Products and Services
    13.4.4. Financial Overview
    13.4.5. SWOT Analysis
    13.4.6. Key Developments
    13.5. ASTRAZENECA
    13.5.1. Key Facts
    13.5.2. Business Description
    13.5.3. Products and Services
    13.5.4. Financial Overview
    13.5.5. SWOT Analysis
    13.5.6. Key Developments
    13.6. TEVA PHARMACEUTICAL INDUSTRIES LTD.
    13.6.1. Key Facts
    13.6.2. Business Description
    13.6.3. Products and Services
    13.6.4. Financial Overview
    13.6.5. SWOT Analysis
    13.6.6. Key Developments
    13.7. AEROGEN LTD.
    13.7.1. Key Facts
    13.7.2. Business Description
    13.7.3. Products and Services
    13.7.4. Financial Overview
    13.7.5. SWOT Analysis
    13.7.6. Key Developments
    13.8. HOVIONE
    13.8.1. Key Facts
    13.8.2. Business Description
    13.8.3. Products and Services
    13.8.4. Financial Overview
    13.8.5. SWOT Analysis
    13.8.6. Key Developments
    13.9. HANTEL TECHNOLOGIES
    13.9.1. Key Facts
    13.9.2. Business Description
    13.9.3. Products and Services
    13.9.4. Financial Overview
    13.9.5. SWOT Analysis
    13.9.6. Key Developments
    13.10. H AND T PRESSPART MANUFACTURING LTD..
    13.10.1. Key Facts
    13.10.2. Business Description
    13.10.3. Products and Services
    13.10.4. Financial Overview
    13.10.5. SWOT Analysis
    13.10.6. Key Developments
    14. APPENDIX
    14.1. ABOUT THE INSIGHT PARTNERS
    14.2. GLOSSARY OF TERMS

    The List of Companies

    1. GlaxoSmithKline plc.
    2. Koninklijke Philips N.V.
    3. Boehringer Ingelheim International GmbH
    4. 3M
    5. AstraZeneca
    6. Teva Pharmaceutical Industries Ltd.
    7. Aerogen Ltd.
    8. Hovione
    9. Hantel Technologies
    10. H&T Presspart Manufacturing Ltd..

    TIPHE100001256
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking
    Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
    © Copyright 2021 - The Insight Partners. All rights reserved